Three-Month Blanking Period After A-Fib Ablation Should Be Shortened, Researchers Say
By Elana Gotkine HealthDay Reporter
MONDAY, April 22, 2024 -- The three-month blanking period (BP) after atrial fibrillation (AF) ablation, when recurrences are not thought to predict long-term outcome, is called into question in two studies recently published in Heart Rhythm.
Dan L. Musat, M.D., from the Valley Hospital in Ridgewood, New Jersey, and colleagues enrolled 210 consecutive patients who had cryoballoon pulmonary vein isolation and an implantable loop recorder and examined the time of last confirmed AF episode within the BP. The researchers found that 48 percent of patients had AF recurrence after the three-month BP at 160 ± 86 days. During long-term follow-up, significantly greater AF recurrence was seen for those with recurrent AF and AF burden >0 percent 30 days after ablation compared with those with no AF in the BP.
Benjamin De Becker, M.D., from AZ Sint Jan Bruges in Belgium, and colleagues examined the relationship between early recurrence of atrial tachyarrhythmia (ERAT) and late recurrence based on insertable cardiac monitor data in 165 patients who underwent radiofrequency ablation for paroxysmal or persistent AF. The researchers found that 41 patients experienced late recurrence during the one-year follow-up period. Patients experiencing ERAT had a higher risk for late recurrence (hazard ratio, 6.2), with negative and positive predictive values of 90.5 and 45.7 percent, respectively. Compared with those without recurrence, patients with late recurrence had a significantly higher burden of AF during the BP (7.9 versus 0.0 percent).
"Rather than determining the significance of arrhythmia recurrences based on whether they occur before or after a set time point, a contextual assessment should be made that takes into account their frequency, duration, and clinical impact," Sohaib Virk, B.Med./M.D., and Jonathan M. Kalman, M.B.B.S., Ph.D., from the Royal Melbourne Hospital in Australia, write in an accompanying editorial.
One author from the Musat study disclosed ties to Medtronic.
Abstract/Full Text - De Becker
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Gastroesophageal Reflux Disease Increases Risk for Atrial Fibrillation
TUESDAY, July 2, 2024 -- Gastroesophageal reflux disease (GERD) is associated with an increased incidence of atrial fibrillation, according to a study published online June 2...
Rare Predicted Loss-of-Function Variants, Polygenic Risk Score Linked to Risk of A-Fib
THURSDAY, June 27, 2024 -- Rare predicted loss-of-function (pLOF) variants and a polygenic risk score (PRS) are associated with increased atrial fibrillation (AF) risk, according...
Low-Dose Direct Oral Anticoagulants Tied to More Bleeding Episodes
WEDNESDAY, June 19, 2024 -- Patients with atrial fibrillation (AF) on low doses of direct oral anticoagulants (DOACs) have more bleeding episodes than those on standard doses...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.